# Strengthening rheumatology services: Rwanda's path to comprehensive training and care

**Authors:** Janvier Murayire, Kara L Neil, Emile Twagirumukiza, Emile Sebera, Menelas Nkeshimana, Zerihun Abebe, Marie Goretti Baransabira, Rosette Mutuyimana, Augustin Sendegeya, Xavier Chevalier, Jean Paul Rwabihama

PMC · DOI: 10.1093/rap/rkaf071 · 2025-06-05

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** rheumatoid factor (MESH:D001171), rheumatic diseases (MESH:D012216), Bechet's disease (MESH:D004194), osteoarthritis (MESH:D010003), myositis (MESH:D009220), spondyloarthritis (MESH:D013167), autoimmune and rare diseases (MESH:D035583), rheumatoid arthritis (MESH:D001172), musculoskeletal disorders (MESH:D009140), sarcoidosis (MESH:D012507), tendinopathies (MESH:D052256), Rheumatologic conditions (MESH:D020763)
- **Chemicals:** Certolizumab (MESH:D000068582), Rituximab (MESH:D000069283), Sulfasalazine (MESH:D012460), Adalimumab (MESH:D000068879), Tofacitinib (MESH:C479163), cDMARDs (-), Tocilizumab (MESH:C502936)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12208528